• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嵌合登革2型/1型病毒在食蟹猴中诱导免疫反应。

Chimeric dengue type 2/type 1 viruses induce immune responses in cynomolgus monkeys.

作者信息

Butrapet Siritorn, Rabablert Jundee, Angsubhakorn Subhkij, Wiriyarat Witawat, Huang Claire, Kinney Richard, Punyim Sakol, Bhamarapravati Natth

机构信息

Center for Vaccine Development, Institute of Science and Technology for Research and Development, Mahidol University, Bangkok, Thailand.

出版信息

Southeast Asian J Trop Med Public Health. 2002 Sep;33(3):589-99.

PMID:12693596
Abstract

Chimeric dengue type 2/type 1 (DEN2/1) viruses, which contain the structural genes of the dengue-1 (16007) parental virus and the nonstructural genes of the DEN2-PDK53 virus, have been constructed. These DEN2/1 viruses induce high levels of DEN1 virus-specific neutralizing antibodies in mice. In this study, the DEN2/1 viruses induced DEN1 virus-specific neutralizing antibodies without the development of viremia in cynomolgus monkeys. Dengue virus-specific IgM antibodies were detected in the sera of the immunized animals as early as 3 days post-immunization. After challenge with the DEN1-16007 wild-type virus, only a low level of viremia was detected in chimeric DEN2/1 virus-immunized monkeys. A second challenge, with DEN2-16681 virus, was given while the levels of DEN2-specific neutralizing antibodies were very low: infectious Dengue 2 virus could not be detected in sera of the monkeys. A correlation between the level of neutralizing antibody and the incidence of viremia could not be found. In addition, there was no significant increase in the levels of interferon gamma and soluble interleukin 2 receptor in the sera of the challenged monkeys, which suggests a reduction in immunopathogenesis caused by T-cell activation. Our findings suggest that DEN2/1 viruses may used as a live-attenuated candidate vaccine because of their safety, broad immunogenicity, and lower immunopathogenicity.

摘要

嵌合型登革2型/1型(DEN2/1)病毒已构建成功,该病毒含有登革1型(16007)亲本病毒的结构基因和DEN2-PDK53病毒的非结构基因。这些DEN2/1病毒在小鼠体内可诱导产生高水平的登革1型病毒特异性中和抗体。在本研究中,DEN2/1病毒在食蟹猴体内诱导产生登革1型病毒特异性中和抗体,且未出现病毒血症。在免疫动物血清中,早在免疫后3天就检测到了登革病毒特异性IgM抗体。在用登革1型-16007野生型病毒攻击后,在嵌合型DEN2/1病毒免疫的猴子中仅检测到低水平的病毒血症。在登革2型特异性中和抗体水平非常低时,用登革2型-16681病毒进行了第二次攻击:在猴子血清中未检测到感染性登革2型病毒。未发现中和抗体水平与病毒血症发生率之间存在相关性。此外,在受攻击猴子的血清中,干扰素γ和可溶性白细胞介素2受体水平没有显著升高,这表明由T细胞激活引起的免疫病理发生有所减少。我们的研究结果表明,DEN2/1病毒因其安全性、广泛的免疫原性和较低的免疫致病性,可能用作减毒活候选疫苗。

相似文献

1
Chimeric dengue type 2/type 1 viruses induce immune responses in cynomolgus monkeys.嵌合登革2型/1型病毒在食蟹猴中诱导免疫反应。
Southeast Asian J Trop Med Public Health. 2002 Sep;33(3):589-99.
2
Vaccine candidates for dengue virus type 1 (DEN1) generated by replacement of the structural genes of rDEN4 and rDEN4Delta30 with those of DEN1.通过用1型登革病毒(DEN1)的结构基因替换rDEN4和rDEN4Delta30的结构基因而产生的1型登革病毒候选疫苗。
Virol J. 2007 Feb 28;4:23. doi: 10.1186/1743-422X-4-23.
3
Monkeys immunized with intertypic chimeric dengue viruses are protected against wild-type virus challenge.用不同血清型嵌合登革病毒免疫的猴子可抵御野生型病毒攻击。
J Virol. 1996 Jun;70(6):4162-6. doi: 10.1128/JVI.70.6.4162-4166.1996.
4
Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates.四价黄热病-登革热嵌合疫苗在非人灵长类动物中的病毒血症和免疫原性:基因重组、剂量调整及针对野生型登革病毒分离株的抗体反应
Virology. 2002 Jun 20;298(1):146-59. doi: 10.1006/viro.2002.1462.
5
Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys.重组减毒活四价登革病毒疫苗制剂可在恒河猴体内诱导针对四种血清型中每一种的平衡、广泛且具有保护性的中和抗体反应。
J Virol. 2005 May;79(9):5516-28. doi: 10.1128/JVI.79.9.5516-5528.2005.
6
Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination.四价减毒活登革病毒疫苗接种后恒河猴对登革病毒攻击的保护作用。
J Infect Dis. 2006 Jun 15;193(12):1658-65. doi: 10.1086/503372. Epub 2006 May 9.
7
Dengue-3 (16562) PGMK 33 vaccine: neurovirulence, viremia and immune responses in Macaca fascicularis.登革热3型(16562)PGMK 33疫苗:食蟹猴的神经毒性、病毒血症及免疫反应
Southeast Asian J Trop Med Public Health. 1994 Sep;25(3):554-9.
8
Induction of neutralizing antibodies and partial protection from viral challenge in Macaca fascicularis immunized with recombinant dengue 4 virus envelope glycoprotein expressed in Pichia pastoris.用毕赤酵母表达的重组登革4型病毒包膜糖蛋白免疫食蟹猴后诱导产生中和抗体并对病毒攻击提供部分保护。
Am J Trop Med Hyg. 2003 Aug;69(2):129-34.
9
Efficacy of a live attenuated tetravalent candidate dengue vaccine in naïve and previously infected cynomolgus macaques.一种减毒活四价登革热候选疫苗在未感染和既往感染食蟹猴中的效力
Vaccine. 2007 Jul 20;25(29):5409-16. doi: 10.1016/j.vaccine.2007.04.079. Epub 2007 May 21.
10
Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates.重组嵌合黄热-登革2型病毒在非人灵长类动物中具有免疫原性和保护性。
J Virol. 2000 Jun;74(12):5477-85. doi: 10.1128/jvi.74.12.5477-5485.2000.

引用本文的文献

1
Potential Role of Flavivirus NS2B-NS3 Proteases in Viral Pathogenesis and Anti-flavivirus Drug Discovery Employing Animal Cells and Models: A Review.黄病毒 NS2B-NS3 蛋白酶在病毒发病机制和利用动物细胞及模型的抗黄病毒药物研发中的潜在作用:综述。
Viruses. 2021 Dec 28;14(1):44. doi: 10.3390/v14010044.
2
Mammalian animal models for dengue virus infection: a recent overview.登革热病毒感染的哺乳动物动物模型:最新综述。
Arch Virol. 2022 Jan;167(1):31-44. doi: 10.1007/s00705-021-05298-2. Epub 2021 Nov 10.
3
Utility, limitations, and future of non-human primates for dengue research and vaccine development.
非人灵长类动物在登革热研究和疫苗开发中的应用、局限性及未来
Front Immunol. 2014 Sep 24;5:452. doi: 10.3389/fimmu.2014.00452. eCollection 2014.
4
Substitution of the premembrane and envelope protein genes of Modoc virus with the homologous sequences of West Nile virus generates a chimeric virus that replicates in vertebrate but not mosquito cells.用西尼罗河病毒的同源序列替换莫多克病毒的前膜蛋白基因和包膜蛋白基因,可产生一种嵌合病毒,该病毒能在脊椎动物细胞而非蚊细胞中复制。
Virol J. 2014 Aug 24;11:150. doi: 10.1186/1743-422X-11-150.
5
Viral kinetics of primary dengue virus infection in non-human primates: a systematic review and individual pooled analysis.非人类灵长类动物中初次登革病毒感染的病毒动力学:系统评价和个体合并分析。
Virology. 2014 Mar;452-453:237-46. doi: 10.1016/j.virol.2014.01.015. Epub 2014 Feb 14.
6
Development of DENVax: a chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever.DENVax 的研发:一种基于嵌合登革热 2 型 PDK-53 的四价疫苗,用于预防登革热。
Vaccine. 2011 Sep 23;29(42):7251-60. doi: 10.1016/j.vaccine.2011.07.020. Epub 2011 Jul 21.
7
Chimeric dengue 2 PDK-53/West Nile NY99 viruses retain the phenotypic attenuation markers of the candidate PDK-53 vaccine virus and protect mice against lethal challenge with West Nile virus.嵌合登革热2型PDK-53/西尼罗河病毒NY99保留了候选PDK-53疫苗病毒的表型减毒标记,并保护小鼠免受西尼罗河病毒致死性攻击。
J Virol. 2005 Jun;79(12):7300-10. doi: 10.1128/JVI.79.12.7300-7310.2005.
8
ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy.嵌合西尼罗河病毒减毒活疫苗:安全性、免疫原性和有效性的临床前评估
J Virol. 2004 Nov;78(22):12497-507. doi: 10.1128/JVI.78.22.12497-12507.2004.
9
Safety and efficacy of chimeric yellow Fever-dengue virus tetravalent vaccine formulations in nonhuman primates.嵌合黄热病-登革热病毒四价疫苗制剂在非人灵长类动物中的安全性和有效性。
J Virol. 2004 May;78(9):4761-75. doi: 10.1128/jvi.78.9.4761-4775.2004.
10
Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development.登革2型PDK-53病毒作为四价登革疫苗开发的嵌合载体。
J Virol. 2003 Nov;77(21):11436-47. doi: 10.1128/jvi.77.21.11436-11447.2003.